Recurrence and survival after curative‐intent treatment for colorectal liver metastases: Implications for adjuvant liver‐directed regional chemotherapy-Reference-Cited by-同舟云学术

Recurrence and survival after curative‐intent treatment for colorectal liver metastases: Implications for adjuvant liver‐directed regional chemotherapy

Published:2021-11-18 Issue:4 Volume:125 Page:664-670
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:Journal of Surgical Oncology

Author:

Kolbeinsson Hordur M.¹²^ORCID,Hoppe Allison²,Walker Jessica²,Chandana Sreenivasa³,Assifi M. Mura¹²⁴,Chung Mathew¹²⁴,Wright Gerald Paul¹²⁴

Affiliation:

1. Spectrum Health General Surgery Residency Grand Rapids Michigan USA

2. Department of Surgery Michigan State University Grand Rapids Michigan USA

3. Cancer and Hematology Centers of Western Michigan Grand Rapids Michigan USA

4. Division of Surgical Oncology Spectrum Health Medical Group Grand Rapids Michigan USA

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26755

Reference28 articles.

1. National Cancer Institute. Surveillance epidemiology and end results program. 2020. Accessed December 8 2020.https://seer.cancer.gov/explorer/application.html?site=40%26data_type=1%26graph_type=4%26compareBy=sex%26chk_sex_1=1%26race=1%26age_range=1%26advopt_precision=1

2. Epidemiology and Management of Liver Metastases From Colorectal Cancer

3. Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases

4. Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

5. A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection